Agios Pharmaceuticals, Inc. Common Stock Earnings Dividend
Earnings Summary
Revenue | $44.75Mn |
Net Profits | $-100.7Mn |
Net Profit Margins | -225.06% |
Agios Pharmaceuticals, Inc. Common Stock’s revenue jumped 259.25% since last year same period to $44.75Mn in the Q2 2026. On a quarterly growth basis, Agios Pharmaceuticals, Inc. Common Stock has generated 115.68% jump in its revenue since last 3-months.
Agios Pharmaceuticals, Inc. Common Stock’s net profit jumped 10.1% since last year same period to $-100.7Mn in the Q2 2026. On a quarterly growth basis, Agios Pharmaceuticals, Inc. Common Stock has generated -1.61% fall in its net profits since last 3-months.
Agios Pharmaceuticals, Inc. Common Stock’s net profit margin jumped 74.98% since last year same period to -225.06% in the Q2 2026. On a quarterly growth basis, Agios Pharmaceuticals, Inc. Common Stock has generated 52.89% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.86 |
EPS Estimate Current Year | -1.86 |
Agios Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -1.86 - a -3.91% fall from last quarter’s estimates.
Agios Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -1.86.
Key Ratios
Earning Per Share (EPS) | -1.69 |
Agios Pharmaceuticals, Inc. Common Stock’s earning per share (EPS) jumped 12.44% since last year same period to -1.69 in the Q2 2026. This indicates that the Agios Pharmaceuticals, Inc. Common Stock has generated 12.44% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-07-30 | -1.86 | -1.69 | 9.14% |
2026-04-29 | -1.79 | -1.69 | 5.59% |
